Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.
about
Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiationNovel perspectives on therapeutic modulation of the gut microbiotaA Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent ModelsThe intestinal microbiome in early life: health and diseaseImpact of the gut microbiota on rodent models of human diseaseMucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine.Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.A physicians' wish list for the clinical application of intestinal metagenomics.Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease.Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient MiceLactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in miceAnti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.Interactions between Obesity Status and Dietary Intake of Monounsaturated and Polyunsaturated Oils on Human Gut Microbiome Profiles in the Canola Oil Multicenter Intervention Trial (COMIT).Extracellular molecular effectors mediating probiotic attributes.Defects in the adherens junction complex (E-cadherin/ β-catenin) in inflammatory bowel disease.Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers.Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple SclerosisChanges in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.Indole - the scent of a healthy 'inner soil'.Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis.Commentary: The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis - Authors' reply.Live Faecalibacterium prausnitzii Does Not Enhance Epithelial Barrier Integrity in an Apical Anaerobic Co-Culture Model of the Large Intestine.Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer.Effects of Supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on Intestinal Epithelial Cells and a Rat Model of 5-Fluorouracil-Induced Mucositis.Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii.Diet Can Impact Microbiota Composition in Children With Autism Spectrum DisorderThe Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating InflammationA bacterial immunomodulatory protein with lipocalin-like domains facilitates host-bacteria mutualism in larval zebrafishAlterations in the Abundance and Co-occurrence of and in the Colonic Mucosa of Inflammatory Bowel Disease SubjectsDifferential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms
P2860
Q24658452-5CE9E4EE-3085-4164-AD8B-2A203E56BC56Q26745706-6515ED59-8BE7-47A6-85F2-8CEA5CB41D8EQ26795697-C8034BD9-F4C7-4B6F-9A25-AC9B88672439Q26996343-15E59D2A-7B1D-4ABE-95A3-CEB9F7231DF6Q28087215-C44C6342-78F8-4E95-B3AF-4328E6C2F048Q30988830-364FE468-ED2E-4432-B012-1AC89E2D2403Q33650357-76CA9A55-60BB-45F4-B99C-FB585FA0B0A6Q34553267-ECB75B3C-8907-4D94-A5EE-A8875DF9FFB4Q35003724-A7B1969F-953A-4456-A980-75ED7A4EC09EQ35105246-72F7FED3-B413-4F6A-BC11-1F1033941D2DQ35148869-785F9FC2-2A49-4775-9B04-71CD97E6C898Q35336737-C85A28BC-FD99-4CB8-B456-00FB57FBE459Q35530189-B7E4A7E3-3395-4D39-9C8D-645C45874028Q35570643-9F897EC6-E3C9-4EA7-8575-5617BCE3360CQ35611149-4005C4BF-BE2C-4487-BA0A-B37A70820553Q35809949-2AAA4D91-E596-490F-9F8D-2D1C79A38AFFQ36191384-F155DF1E-D2A7-4A84-B90C-2F09B160BF0CQ36500198-8167363D-2FE4-4919-90C2-AD699112B389Q37118457-7EE50409-B464-454C-B03D-A56F2AEBB788Q37323347-0BBBE901-0047-4284-B9CD-A9894B2974D1Q38239242-7F973DB2-C385-4445-830F-60BE5233E6F7Q38252679-0183F09F-AA8C-4D67-A7E3-82680E3746B2Q39065664-BD912B49-5E21-47C6-80E7-2D8F1583A192Q39413531-7BDED025-0484-4175-A7F7-89833EBA8089Q39434933-8E965BA9-B388-4CCD-9397-372A430E0238Q40287893-9784DA46-3A20-4863-B03D-39E3D249698BQ41981609-ED90C9E3-3412-4C1E-A8E9-F32EEBEEE050Q42321298-B7470CAB-AF77-4AA1-8C15-8C67F24A5157Q42358507-3C5C2DD1-F725-4075-980F-1336D08289C9Q43822090-988A7315-33B1-46ED-B8C7-AEB378D068C6Q47168538-C8A3B3ED-2777-4122-934A-D43CE0BCE7FEQ47568226-D69F9898-EACC-46D2-B65F-D27A35E49226Q47888594-A6B6B109-E86C-4EBC-A7D1-1CBA5916A74EQ53688957-43A80B92-3F16-4E4E-9ECD-2FEA86E7889BQ55198895-97BC7B7D-548A-4BC3-AFA5-607A73C52370Q57173953-CE1F6B5E-BBA4-49BB-A748-D7C6FC09E366Q57174271-07607E67-D04B-4C43-B44A-C2606E8FF09EQ58606602-EE82AD47-2D82-4108-AE6B-39C1E5B99C84Q58758724-708DB726-57A0-486F-9C3A-38041F7D4151Q58759764-67ABF233-51E1-4636-9D63-C252BF409EB0
P2860
Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Faecalibacterium prausnitzii s ...... function in mice DSS colitis.
@en
Faecalibacterium prausnitzii s ...... function in mice DSS colitis.
@nl
type
label
Faecalibacterium prausnitzii s ...... function in mice DSS colitis.
@en
Faecalibacterium prausnitzii s ...... function in mice DSS colitis.
@nl
prefLabel
Faecalibacterium prausnitzii s ...... function in mice DSS colitis.
@en
Faecalibacterium prausnitzii s ...... function in mice DSS colitis.
@nl
P2093
P2860
P1476
Faecalibacterium prausnitzii s ...... r function in mice DSS colitis
@en
P2093
Anders H Carlsson
Emily Postma
Fathima Håkansson
Isabelle Olivier
Johan D Söderholm
Olena Yakymenko
P2860
P304
P356
10.3109/00365521.2013.828773
P50
P577
2013-08-26T00:00:00Z